Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebaston Thankarajan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Analytical Chemistry|June 3, 2021
Quantification of Drug Release Degree <i>In Vivo</i> Using Antibody-Guided, Dual-NIR-Dye Ratiometric SystemEbaston Thankarajan, Suchita Jadhav, Galia Luboshits, et al.
Photodiagnosis and Photodynamic Therapy|January 15, 2022
A novel, dual action chimera comprising DNA methylating agent and near-IR xanthene-cyanine photosensitizer for combined anticancer therapyEbaston Thankarajan, Dipak Walunj, Andrii Bazylevich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 12, 2022
Antibody guided activatable NIR photosensitizing system for fluorescently monitored photodynamic therapy with reduced side effectsEbaston Thankarajan, Helena Tuchinsky, Sarit Aviel-Ronen, et al.
Bioconjugate Chemistry|June 11, 2021
Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer CellsDvir Poplinger, Maksym Bokan, Arkadi Hesin, et al.
Chembiochem : a European Journal of Chemical Biology|April 24, 2023
SNAP-Tag-Targeted MRI-Fluorescent Multimodal ProbesEbaston Thankarajan, Shimrit Oz, Abed Saady, et al.
European Journal of Medicinal Chemistry|September 10, 2021
Targeted methylation facilitates DNA double strand breaks and enhances cancer suppression: A DNA intercalating/methylating dual-action chimera AmonafidazeneDipak Walunj, Ebaston Thankarajan, Chandrashekhar Prasad, et al.
Oncoimmunology|June 25, 2024
Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor modelsHiroshi Fukushima, Aki Furusawa, Seiichiro Takao, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Analytical Chemistry|June 3, 2021
Quantification of Drug Release Degree <i>In Vivo</i> Using Antibody-Guided, Dual-NIR-Dye Ratiometric SystemEbaston Thankarajan, Suchita Jadhav, Galia Luboshits, et al.
Photodiagnosis and Photodynamic Therapy|January 15, 2022
A novel, dual action chimera comprising DNA methylating agent and near-IR xanthene-cyanine photosensitizer for combined anticancer therapyEbaston Thankarajan, Dipak Walunj, Andrii Bazylevich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 12, 2022
Antibody guided activatable NIR photosensitizing system for fluorescently monitored photodynamic therapy with reduced side effectsEbaston Thankarajan, Helena Tuchinsky, Sarit Aviel-Ronen, et al.
Bioconjugate Chemistry|June 11, 2021
Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer CellsDvir Poplinger, Maksym Bokan, Arkadi Hesin, et al.
Chembiochem : a European Journal of Chemical Biology|April 24, 2023
SNAP-Tag-Targeted MRI-Fluorescent Multimodal ProbesEbaston Thankarajan, Shimrit Oz, Abed Saady, et al.
European Journal of Medicinal Chemistry|September 10, 2021
Targeted methylation facilitates DNA double strand breaks and enhances cancer suppression: A DNA intercalating/methylating dual-action chimera AmonafidazeneDipak Walunj, Ebaston Thankarajan, Chandrashekhar Prasad, et al.
Oncoimmunology|June 25, 2024
Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor modelsHiroshi Fukushima, Aki Furusawa, Seiichiro Takao, et al.
Pageof 1